Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US

INTRODUCTION: Multiple myeloma (MM) is a malignancy of plasma cells; most MM patients will eventually relapse or become refractory to treatment. Treating MM patients remains a challenge since patients eventually progress through several lines of therapy (LOTs), requiring the use of multiple MM drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagannath, Sundar, Joseph, Nedra, He, Jinghua, Crivera, Concetta, Fu, Alex Z., Garret, Ashraf, Shah, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593112/
https://www.ncbi.nlm.nih.gov/pubmed/34694578
http://dx.doi.org/10.1007/s40487-021-00175-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593112/
https://www.ncbi.nlm.nih.gov/pubmed/34694578
http://dx.doi.org/10.1007/s40487-021-00175-z

Ejemplares similares